"Hepatocellular carcinoma: A life-threatening disease"

Area of Science:

• Oncology
• Hepatology
• Cancer Research

Background:

• Hepatocellular Carcinoma (HCC) is the most common primary liver cancer and a leading cause of cancer death globally.
• HCC incidence is projected to rise, with males affected three to four times more frequently than females.
• Hepatitis C Virus (HCV)-related liver cancer is rapidly increasing in the US due to limited treatment options.

Purpose of the Study:

• To highlight the increasing incidence and mortality of Hepatocellular Carcinoma (HCC).
• To underscore the limitations of current HCC treatment strategies.
• To emphasize the critical need for developing new drugs and personalized medicine for HCC.

Main Methods:

• Review of epidemiological data on liver cancer incidence and mortality.
• Analysis of current therapeutic interventions for HCC.
• Identification of gaps in HCC treatment and patient prognosis.

Main Results:

• Liver cancer incidence is projected to reach 95,374 new cases by 2020.
• HCC is the third leading cause of cancer-related deaths worldwide.
• Despite available treatments like transplantation, resection, and chemotherapy, patient prognosis remains poor.

Conclusions:

• Liver transplantation offers high survival rates but is limited by donor scarcity.
• There is an urgent need for the development of targeted therapies and personalized medicine for Hepatocellular Carcinoma.
• Addressing the rising incidence of HCC requires innovative treatment strategies beyond current options.